“…In this regard, thiazole derivatives have been shown to exhibit antiviral, antibacterial, antifungal, antidiabetic, antioxidant, anti-inflammatory, anticancer, and analgesic properties. − They are also found in 18 clinically approved drugs (FDA-approved), including antitumor drugs (epothilone and tiazofurin), anti-inflammatory drugs (meloxicam), antifungal drugs (isavuconazole), antiparasitic drugs (thiabendazole and nitazoxanide), antigout drugs (febuxostat), antithrombotic drugs (edoxaban), antiulcer drugs (nizatidine and famotidine), and antibacterial drugs (aztreonam, sulfathiazole, cefepime, and ceftriaxone) (Figure ). − Because of the simplicity of chemical achievement as well as structural optimization, thiazole-based scaffolds are the most attractive heterocycles in synthetic medicinal chemistry. ,, Furthermore, phenoxyacetamide and its derivatives are pharmacologically active molecules with anticancer, antiviral, antioxidant, anti-inflammatory, antiparasitic, antibacterial, and antihyperglycemic effects, as well as antituberculosis and MAO-A inhibitor activity. − AdipoRon VI (Figure ), a phenoxyacetamide medication, has received a lot of interest in this respect as a potential therapy for obesity, cardiovascular disease, diabetes, and nonalcoholic fatty liver disease. Moreover, quinoxaline derivatives have been the focus of substantial investigation since they have emerged as an important heterocyclic moiety with a varied spectrum of physicochemical and biological functions including antibacterial, antitubercular, antimalarial, antiviral, anti-inflammatory, antifungal, anticancer, antiproliferative, antitumor, and anticonvulsant properties. − They have a wide variety of biological actions.…”